LOW ENERGY ENDOCAPSULAR PHACO (LEEP) DEVICE
Report
- Report Number
- 3012123033-2017-00004
- Event Type
- Injury
- Date Received
- December 19, 2017
- Date of Event
- August 7, 2017
- Report Date
- December 19, 2017
- Manufacturer
- IANTECH, INC.
- Product Code
- HNQ
- PMA / PMN Number
- EXEMPT
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MD, US
- Reporter Occupation
- PHYSICIAN
Narratives
THE DEVICE WAS DISCARDED BY THE USER AND IS NOT AVAILABLE FOR EVALUATION. THE DEVICE HISTORY RECORDS WERE REVIEWED FOR THIS MANUFACTURING LOT AND THERE WERE NO DISCREPANCIES OR UNUSUAL FINDINGS THAT RELATE TO THE REPORTED EVENT. THE EVENT WAS ATTRIBUTED TO PATIENT MOVEMENT DURING THE PROCEDURE AND THERE WAS NO REPORT OF A DEVICE MALFUNCTION. CAPSULAR BAG DAMAGE AND VITREOUS LOSS IS AN INHERENT RISK OF CATARACT SURGERY. (B)(4).
A PATIENT UNDERWENT CATARACT SURGERY IN THE RIGHT EYE ON (B)(6) 2017 WHERE THE LEEP DEVICE WAS USED TO SECTION THE CATARACTOUS LENS INTO FRAGMENTS. DURING SURGERY, A FEMTOSECOND LASER WAS USED FOR NUCLEUS FRAGMENTATION, AFTER WHICH THE LEEP DEVICE WAS INTRODUCED INTO THE EYE. WHILE THE LEEP WAS IN THE EYE AND PRIOR TO MAKING THE FIRST RETRACTION, THE PATIENT RAISED HER HEAD UNEXPECTEDLY. THERE WERE NO OTHER DEVICE IN THE EYE AT THE TIME OF PATIENT MOVEMENT. THE LEEP WAS RETRACTED FROM THE EYE AND THE SURGEON PROCEEDED WITH LENS REMOVAL. WHEN THE FIRST QUADRANT WAS REMOVED IT WAS DISCOVERED THAT THE POSTERIOR CAPSULE HAD TORN AND VITREOUS FLUID WAS PRESENT. A VITRECTOMY WAS PERFORMED AND THE INTRAOCULAR LENS WAS IMPLANTED WITHOUT INCIDENT. POSTOPERATIVELY THE PATIENT IS STABLE AND THERE IS NO ADVERSE IMPACT ON THE PATIENT'S VISION AND NO SEQUELAE. THE SURGEON ATTRIBUTED THE CAPSULAR TEAR TO PATIENT MOVEMENT DURING CLOSURE OF THE LEEP.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 910431 | LOW ENERGY ENDOCAPSULAR PHACO (LEEP) DEVICE | OPHTHALMIC HOOK | HNQ | IANTECH, INC. | FG-11881 | FG20170605-01 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 77 YR | Required Intervention |